Dr Neil Murray (ReNewVax)

  • AMR-reverse-vaccinology-FI
    Article

    Accelerating AMR vaccine development

    2023-11-01T10:00:17

    Dr Neil Murray, Chief Executive of ReNewVax, explores the importance of new bacterial vaccines in the context of antimicrobial resistance and examines how the principle of reverse vaccinology could help to create more accessible and cost-effective vaccines.